BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24401959)

  • 1. Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI.
    Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Vogel H; Yeom KW; Fisher PG; Partap S
    J Neurooncol; 2014 Feb; 116(3):617-23. PubMed ID: 24401959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse patterns in pediatric embryonal central nervous system tumors.
    Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
    J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?
    Martinez S; Khakoo Y; Gilheeney S; Kramer K; Wolden S; Souweidane M; Dunkel IJ
    Pediatr Blood Cancer; 2014 May; 61(5):853-4. PubMed ID: 24375894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
    Fouladi M; Blaney SM; Poussaint TY; Freeman BB; McLendon R; Fuller C; Adesina AM; Hancock ML; Danks MK; Stewart C; Boyett JM; Gajjar A
    Cancer; 2006 Nov; 107(9):2291-7. PubMed ID: 17019740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
    Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal cytarabine for central nervous system embryonal tumors in children and young adults.
    Partap S; Murphy PA; Vogel H; Barnes PD; Edwards MS; Fisher PG
    J Neurooncol; 2011 Jul; 103(3):561-6. PubMed ID: 20859651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.
    Stevens SP; Main C; Bailey S; Pizer B; English M; Phillips R; Peet A; Avula S; Wilne S; Wheatley K; Kearns PR; Wilson JS
    J Neurooncol; 2018 Sep; 139(3):507-522. PubMed ID: 29948767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
    Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
    Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraneural metastasis in intracranial tumors in children: the experience of a single center.
    Varan A; Sari N; Akalan N; Söylemezoğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    J Neurooncol; 2006 Sep; 79(2):187-90. PubMed ID: 16645723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children.
    Korones DN; Butterfield R; Meyers SP; Constine LS
    J Neurooncol; 2001 May; 53(1):33-8. PubMed ID: 11678428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
    MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
    Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
    Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
    J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
    Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical decision-making in the management of childhood tumors of the CNS disseminated at presentation.
    Kirkman MA; Hayward R; Phipps K; Aquilina K
    J Neurosurg Pediatr; 2018 Jun; 21(6):563-573. PubMed ID: 29624145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system tumors in chinese children under the age of 3: a population study.
    Liu AP; Shing MM; Yuen HL; Li CH; Ling SC; Luk CW; Ha SY; Li CK; Chan GC
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):94-103. PubMed ID: 24608077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Presentation: Rare Occurrence of an Adolescent Male Presenting With an ATRT and Simultaneous Low-grade Glioneuronal Tumor.
    Cascio M; Rivera-Zengotita M; Fort J
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e456-e459. PubMed ID: 28731919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes.
    Meyers SP; Khademian ZP; Biegel JA; Chuang SH; Korones DN; Zimmerman RA
    AJNR Am J Neuroradiol; 2006 May; 27(5):962-71. PubMed ID: 16687525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors.
    Hukin J; Siffert J; Velasquez L; Zagzag D; Allen J
    Neuro Oncol; 2002 Oct; 4(4):253-60. PubMed ID: 12356355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.